Premium
Quinapril and blood lipids.
Author(s) -
Koskinen P,
Manninen V,
Eisalo A
Publication year - 1988
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.1988.tb03409.x
Subject(s) - quinapril , blood lipids , medicine , angiotensin converting enzyme , placebo , cholesterol , lipid profile , endocrinology , pharmacology , ace inhibitor , blood pressure , pathology , alternative medicine
To assess the effects of angiotensin‐converting enzyme inhibition with quinapril on blood lipid profile, serum total cholesterol and triglycerides, together with high‐density and low‐density lipoprotein cholesterol were analysed in 23 hypertensive patients receiving either placebo (7 patients) or quinapril hydrochloride (16 patients). After 12 weeks of therapy there were no significant changes in blood lipids in either group. No unfavourable changes in blood lipid profile were observed even after 1 year of therapy with quinapril hydrochloride in 13 patients.